Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 2 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 12297207

    Maytansinoid derivatives, conjugates thereof, and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  2. US 12297186

    Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

    AGOMAB SPAIN, S.L.U. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  3. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  4. US 12281140

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  5. US 12281079

    Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Lead Discovery Center GmbH · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  6. US 12264167

    Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  7. US 12258367

    Glucoside derivative that acts as SGLT1 inhibitor and application thereof

    Medshine Discovery Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  8. US 12252493

    Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

    Mirati Therapeutics, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  9. US 12246012

    Method for treating nervous system injuries using boldine and derivatives thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  10. US 12246014

    Azetidine derivatives

    Ligand UK Development Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  11. US 12247037

    1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders

    Neumora Therapeutics, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  12. US 12234302

    Chitosan derivatives and methods for preparing the same

    PRIMEX EHF · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  13. US 12209180

    Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 28, 2025 · Expires Jan 23, 2045

    granted
  14. CN 119343336

    1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents

    BRACCO IMAGING SPA · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  15. US 12195439

    C1-substituted isopropylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  16. US 12187679

    Hydroxylated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  17. US 12180206

    Aceclidine derivatives, compositions thereof and methods of use thereof

    LENZ THERAPEUTICS OPERATIONS, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  18. US 12171741

    2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  19. US 12168071

    Treprostinil derivatives and their use in pharmaceutical compositions

    United Therapeutics Corporation · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  20. US 12161733

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  21. US 12162855

    Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  22. US 12145925

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  23. US 12145963

    Phenothiazine derivatives and uses thereof

    CAMP4 Therapeutics Corporation · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  24. US 12138276

    Halogenated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted